Literature DB >> 3978246

Interobserver reproducibility of histopathological features in stage II breast cancer. An ECOG study.

K W Gilchrist, L Kalish, V E Gould, S Hirschl, J E Imbriglia, W M Levy, A S Patchefsky, D W Penner, J Pickren, J A Roth.   

Abstract

Eleven surgical pathologists studied microscopic sections from 45 mastectomy specimens of node positive breast cancer patients who had been entered into ECOG clinical trials. Inter-observer reproducibility for histoprognostic features was examined as a prerequisite before a subsequent evaluation of their possible clinical applicability could be undertaken. Histological type, nuclear grade, tubular formation, and lymphoid reactions were studied in the cancerous tissues. Lymph nodal responses (follicular and pulp prominence, sinus histiocytosis) were also examined in a manner that stimulated slide review in routine surgical pathology practice. Numerous two-way comparisons of the pathologists' findings resulted in low levels of agreement (usually much less than 90%). The degree of inter-observer reliability is clinically unacceptable using customary slide review analysis. New ways of examining breast cancer tissues need to be explored in the search for prognostic features which can be applied to the clinical management of breast cancer patients.

Entities:  

Mesh:

Year:  1985        PMID: 3978246     DOI: 10.1007/bf01807642

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  6 in total

Review 1.  Human breast cancer. A model for cancer immunology.

Authors:  M M Black
Journal:  Isr J Med Sci       Date:  1973-03

2.  The interpretive art/science of pathology.

Authors:  R V Hutter
Journal:  CA Cancer J Clin       Date:  1978 May-Jun       Impact factor: 508.702

3.  Cell kinetic measurements of human tumors.

Authors:  J S Meyer
Journal:  Hum Pathol       Date:  1982-10       Impact factor: 3.466

4.  The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4).

Authors:  E R Fisher; R M Gregorio; B Fisher; C Redmond; F Vellios; S C Sommers
Journal:  Cancer       Date:  1975-07       Impact factor: 6.860

5.  Blood vessel invasion and axillary lymph node involvement as prognostic indicators for human breast cancer.

Authors:  R A Weigand; W M Isenberg; J Russo; M J Brennan; M A Rich
Journal:  Cancer       Date:  1982-09-01       Impact factor: 6.860

6.  Analysis of a pathology review of patients with lung tumors.

Authors:  K E Stanley; M J Matthews
Journal:  J Natl Cancer Inst       Date:  1981-06       Impact factor: 13.506

  6 in total
  21 in total

Review 1.  Prognostic factors in breast cancer: current and new predictors of metastasis.

Authors:  D F Hayes; C Isaacs; V Stearns
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-10       Impact factor: 2.673

2.  The Nottingham Prognostic Index in primary breast cancer.

Authors:  M H Galea; R W Blamey; C E Elston; I O Ellis
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

Review 3.  Node negative breast cancer.

Authors:  S M O'Reilly; M A Richards
Journal:  BMJ       Date:  1990-02-10

4.  Determining factors which predict response to primary medical therapy in breast cancer using a single fine needle aspirate with immunocytochemical staining and flow cytometry.

Authors:  I N Fernando; T J Powles; M Dowsett; S Ashley; L McRobert; J Titley; M G Ormerod; N Sacks; M C Nicolson; A Nash
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

5.  Tumor nuclear grade, estrogen receptor, and progesterone receptor: their value alone or in combination as indicators of outcome following adjuvant therapy for breast cancer.

Authors:  B Fisher; E R Fisher; C Redmond; A Brown
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

6.  Proliferative index of breast carcinoma by thymidine labeling: prognostic power independent of stage, estrogen and progesterone receptors.

Authors:  J S Meyer; M Province
Journal:  Breast Cancer Res Treat       Date:  1988-10       Impact factor: 4.872

7.  Prognostic significance of a formalin-resistant nuclear proliferation antigen in mammary carcinomas as determined by the monoclonal antibody Ki-S1.

Authors:  H Kreipe; P Alm; H Olsson; M Hauberg; L Fischer; R Parwaresch
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

8.  Vimentin expression in 98 breast cancers with medullary features and its prognostic significance.

Authors:  S Holck; L Pedersen; T Schiødt; K Zedeler; H Mouridsen
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

9.  Monoclonal antibody BrE-3 participation in a multivariate prognostic model for infiltrating ductal carcinoma of the breast.

Authors:  C M Chan; F S Baratta; L Ozzello; R L Ceriani
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

10.  Relationship between morphological features and kinetic patterns of enhancement of the dynamic breast magnetic resonance imaging and clinico-pathological and biological factors in invasive breast cancer.

Authors:  Oscar Fernández-Guinea; Alejandro Andicoechea; Luis O González; Salomé González-Reyes; Antonio M Merino; Luis C Hernández; Alfonso López-Muñiz; Paz García-Pravia; Francisco J Vizoso
Journal:  BMC Cancer       Date:  2010-01-08       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.